Personalized medicine in nonalcoholic fatty liver disease

키워드

참고문헌 (16)

1. Silvia Sookoian, "Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology", Clinical and Molecular Hepatology, 26(4), pp.461~475 (2020), 대한간학회[DOI]
2. Salatino A, "Computational pipeline for next-generation sequencing(NGS)studies in genetics of NASH", Methods Mol Biol, 2455, pp.203~222 (2022)
3. Brunt EM, "Nonalcoholic fatty liver disease", Nat Rev Dis Primers, 1, pp.15080~ (2015)
4. Friedman SL, "Mechanisms of NAFLD development and therapeutic strategies", Nat Med, 24, pp.908~922 (2018)
5. Sookoian S, "Genetics of nonalcoholic fatty liver disease : from pathogenesis to therapeutics", Semin Liver Dis, 39, pp.124~140 (2019)
6. Sookoian S, "Genetic pathways in nonalcoholic fatty liver disease : insights from systems biology", Hepatology, 72, pp.330~346 (2020)
7. Pirola CJ, "PNPLA3 and COVID-19 outcomes : thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system", Liver Int, 41, pp.2801~2804 (2021)
8. Vujkovic M, "A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation", Nat Genet, 54, pp.761~771 (2022)
9. Yoo T, "Diseasespecific eQTL screening reveals an anti-fibrotic effect of AGXT2in non-alcoholic fatty liver disease", J Hepatol, 75, pp.514~523 (2021)
10. Pirola CJ, "Metabolic dysfunction-associated fatty liver disease : advances in genetic and epigenetic implications", Curr Opin Lipidol, 33, pp.95~102 (2022)
11. Vilar-Gomez E, "Impact of the association between PNPLA3 genetic variation and dietary intake on the risk of significant fibrosis in patients with NAFLD", Am J Gastroenterol, 116, pp.994~1006 (2021)
12. Sookoian S, "Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease", Gut, 69, pp.1483~1491 (2020)
13. Pirola CJ, "The influence of host genetics on liver microbiome composition in patients with NAFLD", EBioMedicine, 76, pp.103858~ (2022)
14. Baselli GA, "Rare ATG7 genetic variants predispose patients to severe fatty liver disease", J Hepatol, 77, pp.596~606 (2022)
15. Pirola CJ, "A rare nonsense mutation in the glucokinase regulator gene is associated with a rapidly progressive clinical form of nonalcoholic steatohepatitis", Hepatol Commun, 2, pp.1030~1036 (2018)
16. Pirola CJ, "Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity", World J Gastroenterol, 24, pp.1601~1615 (2018)

관련 논문AI추천